Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. has successfully closed a $57.5 million public offering, significantly enhancing its financial stability and supporting the development of its key antibody candidates, ADG20 and VYD222, aimed at combating viral diseases, including COVID-19. The results from the Phase 1/2 ‘extreme-dose’ safety trial indicate high confidence in the long-term use of VYD2311, revealing no serious adverse events and demonstrating a favorable safety profile compared to existing COVID vaccines. Additionally, VYD2311's strong manufacturing efficiency and projected robust supply capability position the company well to meet anticipated market demand, further solidifying its strategic outlook.

Bears say

Invivyd Inc has recently experienced a significant downward adjustment in expectations regarding its market share, particularly for PEMGARDA in the immunocompromised patients market, leading to a price target reduction from $3.00 to $1.00 due to capital raise-related dilution. The company’s strategic focus on developing engineered antibodies aims to enhance human immune function; however, the limitations of existing vaccines, such as waning antibody responses and public hesitancy, continue to present challenges. Additionally, while the total addressable market for COVID vaccine revenue is projected at approximately $4 billion, the prevailing concerns around efficacy and the company's competitive position dampen the outlook for its stock.

Invivyd Inc (IVVD) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Buy based on their latest research and market trends.

According to 4 analysts, Invivyd Inc (IVVD) has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.39, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.39, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.